Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
33987 | 118 | 43.1 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
12 | 4 | POLYMER SCIENCE//MATERIALS SCIENCE, PAPER & WOOD//CHEMISTRY, PHYSICAL | 1084170 |
41 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//PHARMACOLOGY & PHARMACY | 99449 |
147 | 2 | SOLID LIPID NANOPARTICLES//POLYMERIC MICELLES//LIPOSOMES | 23275 |
33987 | 1 | LIPID NANOCAPSULES//U646//U1066 | 118 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LIPID NANOCAPSULES | authKW | 6238313 | 38% | 54% | 45 |
2 | U646 | address | 1310011 | 23% | 19% | 27 |
3 | U1066 | address | 1119683 | 13% | 29% | 15 |
4 | IBS CHU | address | 828082 | 3% | 80% | 4 |
5 | EQUIPE PYVER | address | 690067 | 3% | 67% | 4 |
6 | IBS CHU ANGERS | address | 646935 | 4% | 50% | 5 |
7 | SCAHU | address | 582245 | 3% | 75% | 3 |
8 | 9L TUMOUR MODEL | authKW | 517552 | 2% | 100% | 2 |
9 | AMPHIPHILIC PHOSPHOLIPIDS | authKW | 517552 | 2% | 100% | 2 |
10 | INSERM MINT U1066 | address | 517552 | 2% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1322 | 61% | 0% | 72 |
2 | Materials Science, Biomaterials | 509 | 11% | 0% | 13 |
3 | Engineering, Biomedical | 96 | 8% | 0% | 9 |
4 | Chemistry, Multidisciplinary | 75 | 19% | 0% | 22 |
5 | Nanoscience & Nanotechnology | 60 | 8% | 0% | 10 |
6 | Medicine, Research & Experimental | 27 | 7% | 0% | 8 |
7 | Radiology, Nuclear Medicine & Medical Imaging | 17 | 6% | 0% | 7 |
8 | Chemistry, Medicinal | 9 | 3% | 0% | 4 |
9 | Cell & Tissue Engineering | 8 | 1% | 0% | 1 |
10 | Biochemical Research Methods | 6 | 3% | 0% | 4 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | U646 | 1310011 | 23% | 19% | 27 |
2 | U1066 | 1119683 | 13% | 29% | 15 |
3 | IBS CHU | 828082 | 3% | 80% | 4 |
4 | EQUIPE PYVER | 690067 | 3% | 67% | 4 |
5 | IBS CHU ANGERS | 646935 | 4% | 50% | 5 |
6 | SCAHU | 582245 | 3% | 75% | 3 |
7 | INSERM MINT U1066 | 517552 | 2% | 100% | 2 |
8 | MINT MICRO NANOMED BIOMIMET U1066 | 517552 | 2% | 100% | 2 |
9 | CELL TISSUE PATHOL | 345034 | 2% | 67% | 2 |
10 | CIFAB PRIMEX | 345034 | 2% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 11952 | 23% | 0% | 27 |
2 | EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | 6982 | 8% | 0% | 10 |
3 | JOURNAL OF CONTROLLED RELEASE | 4210 | 9% | 0% | 11 |
4 | NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE | 1812 | 3% | 0% | 3 |
5 | PHARMACEUTICAL RESEARCH | 1580 | 6% | 0% | 7 |
6 | MOLECULAR THERAPY-NUCLEIC ACIDS | 855 | 1% | 0% | 1 |
7 | BIOMATERIALS | 841 | 6% | 0% | 7 |
8 | CURRENT PHARMACEUTICAL BIOTECHNOLOGY | 759 | 2% | 0% | 2 |
9 | JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING | 746 | 1% | 0% | 1 |
10 | INTERNATIONAL JOURNAL OF NANOMEDICINE | 723 | 3% | 0% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LIPID NANOCAPSULES | 6238313 | 38% | 54% | 45 | Search LIPID+NANOCAPSULES | Search LIPID+NANOCAPSULES |
2 | 9L TUMOUR MODEL | 517552 | 2% | 100% | 2 | Search 9L+TUMOUR+MODEL | Search 9L+TUMOUR+MODEL |
3 | AMPHIPHILIC PHOSPHOLIPIDS | 517552 | 2% | 100% | 2 | Search AMPHIPHILIC+PHOSPHOLIPIDS | Search AMPHIPHILIC+PHOSPHOLIPIDS |
4 | LABELING OF NANOCARRIERS | 517552 | 2% | 100% | 2 | Search LABELING+OF+NANOCARRIERS | Search LABELING+OF+NANOCARRIERS |
5 | POST INSERTION | 376397 | 3% | 36% | 4 | Search POST+INSERTION | Search POST+INSERTION |
6 | INTRA CAROTID INJECTION | 345034 | 2% | 67% | 2 | Search INTRA+CAROTID+INJECTION | Search INTRA+CAROTID+INJECTION |
7 | BIOCOMPATIBILIY | 258776 | 1% | 100% | 1 | Search BIOCOMPATIBILIY | Search BIOCOMPATIBILIY |
8 | CATIONIC NANOCAPSULE | 258776 | 1% | 100% | 1 | Search CATIONIC+NANOCAPSULE | Search CATIONIC+NANOCAPSULE |
9 | CELL SURVIVAL TEST | 258776 | 1% | 100% | 1 | Search CELL+SURVIVAL+TEST | Search CELL+SURVIVAL+TEST |
10 | CELLULAR AND MOLECULAR THERAPIES | 258776 | 1% | 100% | 1 | Search CELLULAR+AND+MOLECULAR+THERAPIES | Search CELLULAR+AND+MOLECULAR+THERAPIES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LAGARCE, F , PASSIRANI, C , (2016) NUCLEIC-ACID DELIVERY USING LIPID NANOCAPSULES.CURRENT PHARMACEUTICAL BIOTECHNOLOGY. VOL. 17. ISSUE 8. P. 723 -727 | 35 | 76% | 0 |
2 | NASR, M , ABDEL-HAMID, S , (2015) LIPID BASED NANOCAPSULES: A MULTITUDE OF BIOMEDICAL APPLICATIONS.CURRENT PHARMACEUTICAL BIOTECHNOLOGY. VOL. 16. ISSUE 4. P. 322 -332 | 47 | 49% | 6 |
3 | APARICIO-BLANCO, J , TORRES-SUAREZ, AI , (2015) GLIOBLASTOMA MULTIFORME AND LIPID NANOCAPSULES: A REVIEW.JOURNAL OF BIOMEDICAL NANOTECHNOLOGY. VOL. 11. ISSUE 8. P. 1283 -1311 | 41 | 26% | 7 |
4 | LAINE, AL , GRAVIER, J , HENRY, M , SANCEY, L , BEJAUD, J , PANCANI, E , WIBER, M , TEXIER, I , COLL, JL , BENOIT, JP , ET AL (2014) CONVENTIONAL VERSUS STEALTH LIPID NANOPARTICLES: FORMULATION AND IN VIVO FATE PREDICTION THROUGH FRET MONITORING.JOURNAL OF CONTROLLED RELEASE. VOL. 188. ISSUE . P. 1 -8 | 19 | 46% | 12 |
5 | HUYNH, NT , PASSIRANI, C , SAULNIER, P , BENOIT, JP , (2009) LIPID NANOCAPSULES: A NEW PLATFORM FOR NANOMEDICINE.INTERNATIONAL JOURNAL OF PHARMACEUTICS. VOL. 379. ISSUE 2. P. 201-209 | 24 | 33% | 157 |
6 | HIRSJARVI, S , BELLOCHE, C , HINDRE, F , GARCION, E , BENOIT, JP , (2014) TUMOUR TARGETING OF LIPID NANOCAPSULES GRAFTED WITH CRGD PEPTIDES.EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. VOL. 87. ISSUE 1. P. 152-159 | 21 | 40% | 7 |
7 | HIRSJARVI, S , SANCEY, L , DUFORT, S , BELLOCHE, C , VANPOUILLE-BOX, C , GARCION, E , COLL, JL , HINDRE, F , BENOIT, JP , (2013) EFFECT OF PARTICLE SIZE ON THE BIODISTRIBUTION OF LIPID NANOCAPSULES: COMPARISON BETWEEN NUCLEAR AND FLUORESCENCE IMAGING AND COUNTING.INTERNATIONAL JOURNAL OF PHARMACEUTICS. VOL. 453. ISSUE 2. P. 594-600 | 21 | 40% | 13 |
8 | HUREAUX, J , LAGARCE, F , GAGNADOUX, F , CLAVREUL, A , BENOIT, JP , URBAN, T , (2009) THE ADAPTATION OF LIPID NANOCAPSULE FORMULATIONS FOR BLOOD ADMINISTRATION IN ANIMALS.INTERNATIONAL JOURNAL OF PHARMACEUTICS. VOL. 379. ISSUE 2. P. 266-269 | 10 | 91% | 11 |
9 | GROO, AC , BOSSIERE, M , TRICHARD, L , LEGRAS, P , BENOIT, JP , LAGARCE, F , (2015) IN VIVO EVALUATION OF PACLITAXEL-LOADED LIPID NANOCAPSULES AFTER INTRAVENOUS AND ORAL ADMINISTRATION ON RESISTANT TUMOR.NANOMEDICINE. VOL. 10. ISSUE 4. P. 589 -601 | 17 | 32% | 5 |
10 | THOMAS, O , LAGARCE, F , (2013) LIPID NANOCAPSULES: A NANOCARRIER SUITABLE FOR SCALE-UP PROCESS.JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY. VOL. 23. ISSUE 6. P. 555 -559 | 12 | 46% | 5 |
Classes with closest relation at Level 1 |